Earlier this year I started to research what’s known as the “Vaccine Injury Trust Fund,” a “stash” of cash collected on every vaccine sold and given to children and adults in the USA.
That Trust Fund is “financed” by a $0.75 excise tax on each vaccine active recommended by the U.S. Centers for Disease Control and Prevention. On multi-valent vaccines, i.e., those containing more than one disease active e.g., trivalent vaccines like MMR, DTaP, etc., then 75 cents is paid for each valent, or a total of $2.25 for a 3-valent vaccine.
Now, here’s an interesting aspect: The U.S. Department of Treasury collects those excise taxes and also manages the Trust Fund’s investments. Investments? Sounds like there should be quite a stash in that Trust Fund portfolio since the U.S. Vaccine court has paid out just over $3 Billion [$3,159,410,649.38]  in claims and attorneys’ fees as of June 30, 2015. That got me to wondering what the Vaccine Injury Trust Fund is valued at; where the money is invested; and that there should be an accounting of public record posted on the Internet.